Scientists have developed a new kind of brain implant so tiny — smaller than a single cell — that it can be injected into a vein and carried to the brain without the need for risky open-brain surgery. Instead of drilling into the skull, these microscopic implants hitch a ride on immune cells, journey through the bloodstream, cross the intact blood–brain barrier, and settle where they’re needed. Once in place, the implants can deliver targeted electrical stimulation to precise brain regions using near-infrared light for power — effectively enabling neuromodulation with minimal invasiveness.
The core of the technology lies in creating ultra-small, biocompatible electronic chips (about 10 micrometres wide) made from flexible organic semiconductors. These chips convert light into electricity and are linked — via a chemical “click-chemistry” method — to immune cells that naturally patrol the body and respond to inflammation. When injected, the immune cells carry the chips into the brain safely and seamlessly, avoiding immune rejection or damage to surrounding tissue.
In experiments with mice whose brains were inflamed, thousands of these hybrid implants successfully reached the affected site, triggered electrical pulses that activated neurons, and did so without disturbing neighbouring brain cells or causing obvious side-effects over months. The team hopes human trials could begin within a few years.
If this technology — dubbed “circulatronics” — proves successful in humans, it could revolutionise how we treat neurological conditions. It promises a far more accessible, lower-risk alternative to traditional brain implants and could potentially be used to treat a wide range of brain disorders, including neuroinflammation, depression, Alzheimer’s, brain tumors, and even aid recovery from stroke. Beyond therapy, such implants might one day allow continuous, minimally invasive monitoring of brain activity — offering unprecedented insight into how our brains work.